WHEN Brett Harman’s pregnant girlfriend noticed a lump on the back of her leg, they never imagined cancer would strike their ...

Compared with the 24-hour and 48-hour groups, the 72-hour group consistently maintained a statistically significant and clinically meaningful reduction in bone pain for the remaining 3 chemotherapy ...

(HealthDay News) — For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 ...

Lower rates of severe bone pain incidence seen for the 72-hour group vs 24- and 48-hour groups. HealthDay News — For patients with breast cancer, administration of pegfilgrastim 72 hours ...

Administration of pegfilgrastim 72 hours after chemotherapy was associated with a reduction in bone pain and significantly lower rates of severe bone pain incidence. HealthDay News — For patients with ...

Bone marrow biopsy remains central to the diagnosis, classification, and monitoring of hematologic disorders, providing essential morphologic and immunophenotypic information. However, conventional ...